Delivery Order SPE2DB20D3304-SPE2DB24FW6K7
Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $9,255.34 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.72 and a period of performance through November 3, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers, with a ceiling value of $1,395.48. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and there is no set-aside designation indicated. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalation aerosol to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,574.26. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg inhalers to the Defense Logistics Agency (DLA). The contract, valued at $38,854.35, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 18, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of fluticasone propionate HFA (hydrofluoroalkane) inhalers, with a ceiling value of $1,046.32. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 30, 2024. The award is not designated as a set-aside contract....
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12g inhalers. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,991.70 and a completion date of May 28, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $1,066.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 20, 2025 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.58, is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $2,211.56 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with a completion date of November 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW6K7Delivery Order
This federal contract award is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $3,369.53. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 9/12/24, 12:32 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/13/24 |